文献速递痛风与晶体性关节病

HIF-1α在痛风中的作用:代谢、炎症与环境应激的核心调节因子

HIF-1α in Gout: A central regulator of metabolism, inflammation, and environmental stress.
PubMed 文献 · Semin Arthritis Rheum · 2026-03-21

本文综述了缺氧诱导因子1α(HIF-1α)在痛风发病中的潜在作用,提出其作为连接尿酸生成与炎症的统一框架。HIF-1α系统性促进糖酵解和嘌呤代谢,为高尿酸血症提供机制;局部代谢预激维持免疫应答,尤其通过释放白细胞介素-1β。环境应激如缺氧和假性缺氧可稳定HIF-1α并放大炎症信号,支持将痛风重新定义为代谢适应不良性疾病,并提示HIF-1α为潜在治疗靶点。

要点

  • HIF-1α系统性促进糖酵解和嘌呤代谢,可能驱动高尿酸血症。
  • 局部代谢预激通过释放IL-1β维持痛风炎症应答。
  • 缺氧和假性缺氧(如阻塞性睡眠呼吸暂停)稳定HIF-1α并放大炎症信号。

核心结论

  • HIF-1α连接代谢应激、免疫激活和环境暴露,支持将痛风视为代谢适应不良性疾病,并提示其作为潜在治疗靶点。

研究设计与样本

  • 本文为综述,检索并汇总了支持HIF-1α在尿酸生成和炎症中作用的 emerging evidence。

主要发现

  • HIF-1α系统性促进代谢向糖酵解和嘌呤代谢偏移,为高尿酸血症提供合理机制。
  • 局部代谢预激有助于维持免疫应答,尤其通过释放白细胞介素-1β。
  • 环境应激包括缺氧和假性缺氧(如阻塞性睡眠呼吸暂停)可进一步稳定HIF-1α并放大炎症信号。

临床怎么用

  • 可将HIF-1α视为连接代谢与环境因素的核心节点,用于理解痛风发病并探索靶向治疗。

局限性

  • HIF-1α在痛风中的作用仍未被充分探索,本综述基于 emerging evidence,尚需进一步研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Gout is a chronic inflammatory disease characterized by the deposition of monosodium urate crystals in the joints. However, growing research suggests a more complex pathophysiology involving genetic susceptibility, metabolic stress, and environmental factors. Among emerging contributors, hypoxia-inducible factor 1 alpha (HIF-1α) has been proposed as a potential regulator that links these processes, though its role in gout remains underexplored. This review examines the emerging evidence supporting HIF-1α's role in both urate production and inflammation, to offer a unifying framework connecting these contributors to gout pathogenesis. Systemically, HIF-1α has been shown to promote a metabolic shift towards glycolysis and purine metabolism, providing a plausible mechanism for hyperuricemia. Locally, metabolic priming helps sustain immune responses, particularly through the release of interleukin-1 beta. Environmental stressors, including hypoxia and pseudohypoxia (e.g., obstructive sleep apnea), can further stabilize HIF-1α and amplify inflammatory signaling. This framework supports a model in which HIF-1α links metabolic stress, immune activation, and environmental exposures, reframing gout as a disorder of metabolic maladaptation and suggesting HIF-1α as a potential therapeutic target.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Rasheed N, Reyes C, Weisman MH, et al. HIF-1α in Gout: A central regulator of metabolism, inflammation, and environmental stress. Semin Arthritis Rheum. 2026. PMID: 41923672. doi:10.1016/j.semarthrit.2026.152971

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。